Chordoid Meningioma: The Rarest Subtype of Grade II Meningioma
Chordoid meningioma, a rare WHO grade II tumor, is known for its aggressive behavior and high recurrence rate. We report a case of a 44-year-old woman with progressive left-sided weakness, where imaging revealed a 3.0 cm lesion in the right sphenoidal wing with significant midline shift and edema. Following corticosteroid treatment, the patient underwent embolization and complete tumor resection, achieving full motor recovery. Pathology confirmed a chordoid meningioma. Gross total resection is vital to minimize the risk of recurrence, while subtotal resection is linked to higher recurrence, often with elevated MIB-1 scores. Adjuvant radiotherapy may be used in high-risk cases, though it carries a risk of malignant transformation. Early detection, complete resection, and close follow-up are key to optimal outcomes.
Authors
- José Valerio (ORCID: https://orcid.org/0000-0001-7283-5988)
- Noe Santiago Rea (ORCID: https://orcid.org/0009-0004-7489-5086)
- Jorge Zumaeta
- Luis Rey Martinez
Institutions
- Larkin Community Hospital (US)
- Hospital Nacional Cayetano Heredia (PE)
- Larkin University (US)
- Estudios Clínicos Latinoamérica (AR)
- Palmetto General Hospital (US)
- Hospital Base Guillermo Almenara Irigoyen (PE)
Publication Details
- Journal
- Cureus
- Published
- 2024-11-20
- DOI
- https://doi.org/10.7759/cureus.74084
- Primary Topic
- Meningioma and schwannoma management
- Type
- article
- Field-Weighted Citation Impact
- 0.00